Brief: Chinook Therapeutics Announces Promotions Of Tom Frohlich To Chief Operating Officer And Andrew King, D.V.M, Ph.D., To Chief Scientific Officer
09/06/2021 13:48
June 9 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS ANNOUNCES PROMOTIONS OF TOM FROHLICH
TO
CHIEF OPERATING OFFICER AND ANDREW KING, D.V.M, PH.D., TO CHIEF
SCIENTIFIC OFFICER
Source text for Eikon: ID:nGNX8VDXmr
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc